Research on Chemical and Biological Defense — CFDA 12.360

Chem-bio defense obligations at $771.7 million

USAspending.gov records $771,657,370.44 in obligations under CFDA 12.360. Sixteen awards produce that stock. A simple average is about $48,228,586 per award. That average is a quotient of two packet totals, not a typical lab-task order and not a cost per assay. Other Department of Defense chemical-and-biological listings tagged under different CFDA numbers are not mixed into the $771,657,370.44.

The assistance-listing title is RESEARCH ON CHEMICAL AND BIOLOGICAL DEFENSE. CFDA 12.360 is the identifier. Combining 12.360 with broader CBDP or medical-research codes would invent a combined chem-bio total this packet does not contain. Read the $771,657,370.44 as the obligation book tagged 12.360 only.

14 recipients in 9 jurisdictions

Fourteen recipients share 16 awards, or about 1.1 award records per recipient on average. Splitting $771,657,370.44 evenly would assign about $55.1 million per recipient. That density is a large-center pattern: a tiny named-organization headcount carrying one or two very large assistance rows. The packet does not list the 14.

Nine jurisdictions in the geographic count is a research-cluster map, not a nationwide formula. Chem-bio defense research dollars follow funded labs and universities, not equal shares. Place-of-performance amounts are on the program table. Recipient count is organizational, not a census of defense scientists.

Award rows are not a threat census

Among Defense listings, 12.360 is an extremely low-row file: 16 awards against 14 recipients. Award count is a weak proxy for “number of defense research programs” and a worse proxy for agents studied. Recipients (14) tell you how many named organizations sit on the extract; awards (16) tell you how many assistance rows were stored.

The packet does not report select-agent inventories, detector units, or trial enrollments. Citing 16 as pathogens would be a unit error. Keep the units straight: dollars, awards, recipients, jurisdictions. The $771,657,370.44 stock is the obligation figure from USAspending.gov.

Obligations versus chem-bio outlays

The $771,657,370.44 is an obligation total from USAspending.gov. Outlays — cash paid against Research on Chemical and Biological Defense awards — are not in the packet. A concentrated research file can show a large obligation stock while draws follow multi-year technical periods. Deobligations and upward adjustments both move the total.

Use CFDA 12.360 to size this chem-bio research listing in the assistance file. Do not use it as a threat-assessment dashboard. Those series live elsewhere. This page reports the obligation book tagged 12.360.

What the 12.360 tables omit

The program hub lists award-backed obligations from USAspending.gov. It is not a classified program inventory, not a vaccine stockpile, and not a lab-accreditation log. Series that never appear as assistance awards will not show up in the $771,657,370.44. That omission is definitional rather than a gap in the 16 award rows.

Place-of-performance on 9 jurisdictions is a coding field on a concentrated extract. Read the program page before treating those 9 cells as a national chem-bio map. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already paid to research performers.

Where the 12.360 table lives

The program page overlays these four facts. The all-programs index ranks 12.360 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other Defense listings. For 12.360 only, start on the program page.

CFDA 12.360’s 16 awards spread $771,657,370.44 across 14 recipients and 9 jurisdictions. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 1.1 award records per recipient is the density story. Outlays remain a separate column. Source: USAspending.gov assistance awards.

A researcher comparing 12.360 with broader CBDP or medical-research codes should keep CFDA numbers separate. The 14-recipient headcount on 16 awards and 9 jurisdictions is an extremely concentrated research fingerprint, with about $48,228,586 per award. Quote $771,657,370.44 as the USAspending obligation stock for Research on Chemical and Biological Defense only. Pathogen inventories, detector units, and trial enrollments remain outside the packet. Outlays are a separate column.

Questions

How much is obligated for chemical and biological defense research?

USAspending.gov records $771,657,370.44 in obligations for CFDA 12.360. SpendingVault indexes 16 awards, 14 recipients, and 9 jurisdictions. The figure is an obligation sum from assistance awards, not an outlay and not a pathogen count. CFDA 12.360’s $771,657,370.44 is the USAspending obligation stock.

How many awards does CFDA 12.360 carry?

The listing shows 16 awards against 14 recipients, or about 1.1 award records per recipient. A simple average is about $48,228,586 per award. Award count is not a count of detectors or vaccines. Recipient dollars are on the program page.

How many organizations receive 12.360 awards?

The extract lists 14 recipients. Those are organizational recipients on assistance awards tagged 12.360, not a census of defense laboratories. Geographic coding covers 9 jurisdictions. The packet does not name the 14 or publish inventory counts. The packet reports obligations from USAspending.gov, not outlays.

Is $771,657,370.44 already paid for chem-bio research?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 12.360’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or agents studied. The $771,657,370.44 on 16 awards is the obligation figure. The packet reports obligations from USAspending.gov, not outlays.